Partisan Politics Returns To US FDA Congressional Oversight

 
• By Michael McCaughan

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

Food and Drug Administration (FDA) Commissioner Robert Califf speaking at a hearing of the House Committee on Oversight and Accountability at the U.S. Capitol on April 4, 2024
FDA Commissioner Robert Califf had a tough outing on Capitol Hill. • Source: Michael Brochstein/SOPA Images/Shutterstock

More from US FDA

More from Agency Leadership